The Paxman hair loss prevention system is successfully used around the World on a wide range of cancer types with the most commonly used chemotherapy drug regimes.
Hair loss is the most feared side effect of cancer chemotherapy treatment.
Cooling the scalp during selected chemotherapy regimes has shown to reduce or prevent otherwise inevitable total hair loss.
Hair loss prevention is determined by the degree of control in maintaining the scalp at a constant temperature pre, during and post infusion of the chemotherapy drugs.
Overview of the system
Consideration and care has gone into the design of the system in order to meet the needs of both the patient and nursing staff. It is simple to operate with easy to read touch screen displays. The compact nature and manoeuvrability of the system ensures an efficient use of space.
The system comprises of a small compact mobile refrigeration system connected to lightweight silicone caps.
The patient’s scalp is lowered in temperature to approximately 18°C by circulating a special coolant throughout the cap at -4°C.
The scalp cooler is produced in two models, Orbis I for one patient use and the Orbis II for treating two patients simultaneously.
Benefits
- High level of patient tolerance and acceptability
- The risk of hair loss is greatly reduced and patients’ self confidence is therefore improved
- Self image is preserved which leads to positive attitudes towards treatment and cure
- Social life and activities need not be inhibited
- Proven success rates
